Skip to content
Clinical Trials – home

Migraine without aura

  • 12 clinical trials
Quick filters

12 Clinical trials

Migraine+2

Recruiting

Study on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Migraine+2

Recruiting

Study on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Migraine+2

Recruiting

Study on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Migraine+2

Recruiting

Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Migraine without aura

Not yet recruiting

Study of apremilast‑induced headache and migraine in women with migraine without aura

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Apremilast
  • Sponsor:Syddansk Universitet (University of Southern Denmark)

Migraine without aura

Not yet recruiting

Study of the effects of pitolisant on migraine without aura in women

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Gelatin
  • Sponsor:Syddansk Universitet (University of Southern Denmark)
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.